Boston Scientific Corp. (BSX)
72.21
-1.64
(-2.22%)
USD |
NYSE |
Mar 04, 16:00
72.17
-0.04
(-0.06%)
Pre-Market: 07:25
Boston Scientific Cash from Investing (Quarterly) : -512.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -913.00M |
| Intuitive Surgical, Inc. | -209.40M |
| Globus Medical, Inc. | -111.45M |
| ResMed, Inc. | -50.94M |
| Stryker Corp. | -305.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.364B |
| Cash from Financing (Quarterly) | -184.00M |
| Free Cash Flow | 3.658B |
| Free Cash Flow Per Share (Quarterly) | 0.6772 |
| Free Cash Flow to Equity (Quarterly) | 1.086B |
| Free Cash Flow to Firm (Quarterly) | 1.046B |
| Free Cash Flow Yield | 3.39% |